Hyperion Defi Inc (HYPD)

$7.74 -0.34 (-4.21%)
Market Cap 56.23M
Revenue (ttm) 60,000.00
Net Income (ttm) -49.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -83,033.33%
Debt to Equity Ratio -0.96
Volume 518,800
Avg Vol 808,390
Day's Range N/A - N/A
Shares Out 6.96M
Stochastic %K 68%
Beta 2.57
Analysts Strong Buy
Price Target N/A

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology
Sector: Healthcare
Phone: 917 289 1117
Address:
295 Madison Avenue, Suite 2400, New York, United States
Diiiii
Diiiii Oct. 25 at 3:06 AM
$HYPD The 13F filing confirms that Redwood Wealth Management Group, LLC holds 88,780 shares. Hyperliquid Strategies is also joining the HYPE treasury, which will act as a support factor for the HYPE token price, and $HYPD may benefit from the airdrop. Institutional investors might also start buying up $HYPD in increasing amounts from now on. $HYPD. More than just $HYPE.
1 · Reply
StardustNdreams
StardustNdreams Oct. 24 at 10:31 PM
$HYPD gaining green in AH
0 · Reply
StardustNdreams
StardustNdreams Oct. 23 at 8:29 PM
$HYPD now up almost 14% looking good
0 · Reply
StardustNdreams
StardustNdreams Oct. 23 at 7:13 PM
$HYPD 10% is doing good
0 · Reply
Diiiii
Diiiii Oct. 23 at 8:45 AM
$HYPD $HYPD has been partnering with Kinetiq since July to engage in staking activities and also holds Hypurr NFTs. Looking at the details of Kinetiq's airdrop announced yesterday, it looks like HYPD may benefit from the airdrop with some impact. $HYPD. More than just $HYPE.
0 · Reply
URANIO_ARRICCHITO
URANIO_ARRICCHITO Oct. 22 at 12:36 PM
$HYPD A fund has entered in $HYPD ? Forsakringsaktiebolaget Avanza Pension (Sweden) ... or I have understood in a wrong way ?
1 · Reply
Backer59
Backer59 Oct. 21 at 6:48 PM
$HYPD Putting lipstick on a pig. It's still a pig until there's less talk and more action from CEO Jung.🤞😎
1 · Reply
Jwa68
Jwa68 Oct. 21 at 6:23 PM
$HYPD
0 · Reply
BeeDecay
BeeDecay Oct. 21 at 1:52 PM
$HYPD
0 · Reply
Shawna_Crawdfish
Shawna_Crawdfish Oct. 19 at 7:44 PM
$HYPD 26.40… ⏳⌛️🤷🏻‍♂️
0 · Reply
Latest News on HYPD
Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 29, 2025, 8:00 AM EDT - 26 days ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

Sep 27, 2025, 7:30 AM EDT - 4 weeks ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Sep 16, 2025, 8:00 AM EDT - 5 weeks ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 14, 2025, 10:16 AM EDT - 2 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:01 PM EDT - 2 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Aug 8, 2025, 4:05 PM EDT - 2 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 28, 2025, 8:00 AM EDT - 3 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 17, 2025, 8:00 AM EDT - 3 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jul 14, 2025, 4:05 PM EDT - 3 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

Jun 18, 2025, 2:04 PM EDT - 4 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 18, 2025, 8:32 AM EDT - 4 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 3:54 PM EDT - 4 months ago

Eyenovia Surges on Crypto Announcement

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Jun 17, 2025, 2:55 PM EDT - 4 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

May 19, 2025, 5:30 PM EDT - 5 months ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Apr 10, 2025, 7:00 AM EDT - 7 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Mar 20, 2025, 7:00 AM EDT - 7 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 26, 2025, 7:00 AM EST - 8 months ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 24, 2025, 7:00 AM EST - 8 months ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Feb 5, 2025, 7:00 AM EST - 9 months ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 28, 2025, 4:05 PM EST - 9 months ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 15, 2025, 7:00 AM EST - 10 months ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Jan 6, 2025, 7:00 AM EST - 10 months ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Dec 6, 2024, 8:00 AM EST - 11 months ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Eyenovia Provides Update on Restructuring Efforts

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:42 PM EST - 1 year ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Eyenovia Announces Closing of Public Offering

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Eyenovia, Inc. Announces Proposed Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:07 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

Eyenovia Announces Pricing of $5M Registered Direct Offering

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5M Registered Direct Offering

Diiiii
Diiiii Oct. 25 at 3:06 AM
$HYPD The 13F filing confirms that Redwood Wealth Management Group, LLC holds 88,780 shares. Hyperliquid Strategies is also joining the HYPE treasury, which will act as a support factor for the HYPE token price, and $HYPD may benefit from the airdrop. Institutional investors might also start buying up $HYPD in increasing amounts from now on. $HYPD. More than just $HYPE.
1 · Reply
StardustNdreams
StardustNdreams Oct. 24 at 10:31 PM
$HYPD gaining green in AH
0 · Reply
StardustNdreams
StardustNdreams Oct. 23 at 8:29 PM
$HYPD now up almost 14% looking good
0 · Reply
StardustNdreams
StardustNdreams Oct. 23 at 7:13 PM
$HYPD 10% is doing good
0 · Reply
Diiiii
Diiiii Oct. 23 at 8:45 AM
$HYPD $HYPD has been partnering with Kinetiq since July to engage in staking activities and also holds Hypurr NFTs. Looking at the details of Kinetiq's airdrop announced yesterday, it looks like HYPD may benefit from the airdrop with some impact. $HYPD. More than just $HYPE.
0 · Reply
URANIO_ARRICCHITO
URANIO_ARRICCHITO Oct. 22 at 12:36 PM
$HYPD A fund has entered in $HYPD ? Forsakringsaktiebolaget Avanza Pension (Sweden) ... or I have understood in a wrong way ?
1 · Reply
Backer59
Backer59 Oct. 21 at 6:48 PM
$HYPD Putting lipstick on a pig. It's still a pig until there's less talk and more action from CEO Jung.🤞😎
1 · Reply
Jwa68
Jwa68 Oct. 21 at 6:23 PM
$HYPD
0 · Reply
BeeDecay
BeeDecay Oct. 21 at 1:52 PM
$HYPD
0 · Reply
Shawna_Crawdfish
Shawna_Crawdfish Oct. 19 at 7:44 PM
$HYPD 26.40… ⏳⌛️🤷🏻‍♂️
0 · Reply
MissionParabolica
MissionParabolica Oct. 18 at 10:34 PM
Looking for the next Monster runner?🚨🚨 Make sure you have ticker VRME on ur watch. VRME has all the recipe to make a strong move next week ✅Golden cross ✅Compliance PR incoming ✅Treasury updates ✅Momentum building fast Folks are starting to find this beauty 🎯3-5$🎯 $HYPD $GNLN $ASBP $CISS ..2
0 · Reply
Mike827
Mike827 Oct. 16 at 6:44 PM
$HYPD can anyone explain in simple terms what exactly this company does now?🤷🏻‍♀️🤣
2 · Reply
Mike827
Mike827 Oct. 15 at 3:40 PM
$HYPD so it’s clear now that this new company is as worthless as the old one😂🤣 basically it’s a do nothing shell company issuing shares to stay afloat 🤷🏻‍♀️
2 · Reply
LoneBroker
LoneBroker Oct. 14 at 8:37 AM
$HYPD • $7.78 🐻 • RSI 38.81 • ATR 16.88% • vol↓ Support & Resistance — UPDATED 10/14/2025 5 Days | Support: $7.23 – $7.92 | Resistance: $9.50 – $10.18 20 Days | Support: $7.23 – $7.92 | Resistance: $13.36 – $13.71 60 Days | Support: $5.08 – $5.23 | Resistance: $14.20 – $15.00 HYPD remains under selling pressure with RSI 38.81, highlighting weakness. ATR 16.88% indicates elevated movement, while vol↓ suggests waning support. Watch the $7.23–$7.92 zone for potential stabilization. 📌 RSI = momentum (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 4:00 PM ET / 1:00 PM PT
0 · Reply
Jackie_Treehorn
Jackie_Treehorn Oct. 10 at 3:12 AM
$HYPD $HYPE.X $SONN Announcement by end of year. Patiently waiting
2 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 9:49 PM
Keep a close watch on CMCT! $HYPD $IOT $GNS $UP U
0 · Reply
Jsilva999
Jsilva999 Oct. 9 at 8:56 PM
$HYPD does anyone know when will be the next pump attack!!?? Is for a friend!!😁😁😁
0 · Reply
Stiochi
Stiochi Oct. 9 at 1:27 AM
$APLD ’—I took my entire 700% gain from $EYEN $HYPD put it all on this last earnings play. Can’t believe I chose this over $NVTS! Feels like a huge win. ❤️❤️ I’m really excited for tomorrow’s earnings!
0 · Reply
MarRizzo
MarRizzo Oct. 8 at 9:24 PM
$BURU has been on my watchlist since July, and was sure worth the wait ... Avg at $0.19 and holding... Before that had a nice little payday with $HYPD ... DD and patience
0 · Reply
HeavyDtwitter
HeavyDtwitter Oct. 8 at 4:09 PM
$HYPD https://finance.yahoo.com/news/clara-technologies-provides-corporate-amazon-030000449.html
0 · Reply
Backer59
Backer59 Oct. 8 at 2:01 PM
$HYPD Damn, the new guy is no better than the old guy. Same ridiculous compensation package, same bullshit press releases and the same stock price going no where results. I hope the new guy proves me wrong.🤞😎
2 · Reply
LoneBroker
LoneBroker Oct. 8 at 3:13 AM
$HYPD • $9.35 🐻 • RSI 36.78 • ATR 15.33% • vol↓ Support & Resistance — UPDATED 10/07/2025 3 Days | Support: $9.07 – $9.26 | Resistance: $9.44 – $9.63 7 Days | Support: $8.88 – $9.16 | Resistance: $9.54 – $9.82 HYPD Faces renewed pressure as sellers retain control of short-term price action. RSI at 36.78 confirms trend posture, while ATR 15.33% indicates volatility within expected bounds. Support rests near $9.07–$9.26, and short-term resistance aligns between $9.44–$9.63. Volume vol↓ suggests limited participation. 📌 RSI = momentum (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 4:00 PM ET / 1:00 PM PT (Mon–Fri)
0 · Reply